Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations… Grant US-11584949-B2 United States of America 21 Feb 2023
Engineered primate cystine/cysteine degrading enzymes as antineogenic agents Grant US-11426464-B2 United States of America 30 Aug 2022
Human-enzyme mediated depletion of homocysteine for treating patients with… Grant US-11033612-B2 United States of America 15 Jun 2021
Engineered primate cystine/cysteine degrading enzymes for therapeutic uses Grant US-10865403-B2 United States of America 15 Dec 2020
Engineered primate L-methioninase for therapeutic purposes Grant US-10724026-B2 United States of America 28 Jul 2020
Engineered primate cystine/cysteine degrading enzymes as antineogenic agents Grant US-10716856-B2 United States of America 21 Jul 2020
Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations… Grant US-10526638-B2 United States of America 07 Jan 2020
Engineered primate cystine/cysteine degrading enzymes as antineogenic agents Application US-10363311-B2 United States of America 30 Jul 2019
Engineered primate L-methioninase for therapeutic purposes Application US-10233438-B2 United States of America 19 Mar 2019
ENGINEERED PRIMATE CYSTINE/CYSTEINE DEGRADING ENZYMES FOR THERAPEUTIC USES Application WO-2018209211-A1 World Intellectual Property Organisation (WIPO) 15 Nov 2018
Engineered primate L-methioninase for therapeutic purposes Grant US-9624484-B2 United States of America 18 Apr 2017
Engineered primate L-methioninase for therapeutic purposes Grant US-9481877-B2 United States of America 01 Nov 2016